GE HealthCare Files 8-K on Feb 15 Event

TL;DR

**GE HealthCare just filed an 8-K for a Feb 15 event, keeping the market updated on corporate info.**

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on February 16, 2024, reporting an event that occurred on February 15, 2024. The filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 88-2515116, is located at 500 W. Monroe Street, Chicago, IL 60661, and its telephone number is (833) 735-1139. This 8-K is a 'Current Report' filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

Why It Matters

This filing provides updated public information about GE HealthCare Technologies Inc., ensuring transparency and compliance with SEC regulations for investors and the market.

Risk Assessment

Risk Level: low — This 8-K is a routine filing for 'Other Events' and 'Financial Statements and Exhibits,' indicating standard corporate disclosure without immediate red flags.

Key Players & Entities

• GE HealthCare Technologies Inc. (company) — registrant
• February 15, 2024 (date) — date of earliest event reported
• February 16, 2024 (date) — filing date
• Delaware (company) — state of incorporation
• 88-2515116 (company) — IRS Employer Identification No.
• 500 W. Monroe Street, Chicago, IL 60661 (company) — principal executive offices address
• (833) 735-1139 (company) — registrant's telephone number

FAQ

From the Filing

0001193125-24-038569.txt : 20240216 0001193125-24-038569.hdr.sgml : 20240216 20240216171034 ACCESSION NUMBER: 0001193125-24-038569 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240215 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 24649435 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d787884d8k.htm 8-K 8-K false 0001932393 0001932393 2024-02-15 2024-02-15     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 15, 2024     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   500 W. Monroe Street , Chicago , IL   60661 (Address of principal executive offices)   (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139   (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On February 15, 2024, GE HealthCare Technologies Inc. (the “Company”) announced the commencement and pricing of an underwritten offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $82.25 per share ($80.605 per share, net of underwriting discount). The Company is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Of